Cargando…

Rituximab monotherapy become an optimal treatment for primary pulmonary malt lymphoma

Detalles Bibliográficos
Autores principales: Alvarez-Sánchez, A.I., Martínez-Losada, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993361/
https://www.ncbi.nlm.nih.gov/pubmed/29892543
http://dx.doi.org/10.1016/j.lrr.2018.02.004
_version_ 1783330237808902144
author Alvarez-Sánchez, A.I.
Martínez-Losada, C.
author_facet Alvarez-Sánchez, A.I.
Martínez-Losada, C.
author_sort Alvarez-Sánchez, A.I.
collection PubMed
description
format Online
Article
Text
id pubmed-5993361
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-59933612018-06-11 Rituximab monotherapy become an optimal treatment for primary pulmonary malt lymphoma Alvarez-Sánchez, A.I. Martínez-Losada, C. Leuk Res Rep Article Elsevier 2018-02-21 /pmc/articles/PMC5993361/ /pubmed/29892543 http://dx.doi.org/10.1016/j.lrr.2018.02.004 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Alvarez-Sánchez, A.I.
Martínez-Losada, C.
Rituximab monotherapy become an optimal treatment for primary pulmonary malt lymphoma
title Rituximab monotherapy become an optimal treatment for primary pulmonary malt lymphoma
title_full Rituximab monotherapy become an optimal treatment for primary pulmonary malt lymphoma
title_fullStr Rituximab monotherapy become an optimal treatment for primary pulmonary malt lymphoma
title_full_unstemmed Rituximab monotherapy become an optimal treatment for primary pulmonary malt lymphoma
title_short Rituximab monotherapy become an optimal treatment for primary pulmonary malt lymphoma
title_sort rituximab monotherapy become an optimal treatment for primary pulmonary malt lymphoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993361/
https://www.ncbi.nlm.nih.gov/pubmed/29892543
http://dx.doi.org/10.1016/j.lrr.2018.02.004
work_keys_str_mv AT alvarezsanchezai rituximabmonotherapybecomeanoptimaltreatmentforprimarypulmonarymaltlymphoma
AT martinezlosadac rituximabmonotherapybecomeanoptimaltreatmentforprimarypulmonarymaltlymphoma